Market Overview:
The global animal insulin market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for animal-based insulin products due to their high efficacy and safety as compared to human-based insulin products. In addition, the increasing prevalence of diabetes mellitus in animals is also contributing significantly towards the growth of this market. Based on type, porcine insulin held a major share of the global animal insulin market in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to factors such as rising awareness about porcine-derived insulins among veterinarians and pet owners, growing demand for pork meat across regions, and easy availability of porcine-derived insulins compared with other types of animal-based insulins.
Product Definition:
Animal insulin is a hormone that is produced in the pancreas of vertebrates and used in the treatment of diabetes. It lowers blood sugar levels by stimulating the absorption of glucose from the blood into cells.
Porcine Insulin:
Porcine insulin is a form of bovine insulin, which is the same as human insulin but with different quantities of antibodies. It has been used in humans for many years and currently it's being used in various species including swine, poultry and cattle. Porcine insulins are widely used by people suffering from diabetes to treat hypoglycemia (low blood sugar) caused due to illness or injury.
Bovine Insulin:
Bovine insulin is a form of bovine milk insulin. It is produced by the pancreas of bovines (cattle). Bovine insulin has an amino acid structure similar to human insulin and thus it can be used as a replacement for human analogs in many applications. Bovine insulins are available in various forms such as short-acting, intermediate-acting, and long-acting types.
Application Insights:
The application segment includes humans and animals. The human insulin market is segregated into type I and other types. Type I diabetes has a higher prevalence rate as compared to other applications. According to the International Diabetes Federation, approximately 617 million people were affected by diabetes globally in 2018, of which 86% were type II patients and 14% were type I patients.
Prevalence of animal insulin usage in non-food purposes such as companion animals or show animals is low as compared to food applications due to cost constraints associated with the former category.
Regional Analysis:
North America dominated the global animal insulin market in 2017. The presence of a large number of manufacturers coupled with high healthcare expenditure and technological advancements are some factors attributing to its largest share. In addition, increasing demand for meat products is expected to drive the regional market further. Asia Pacific is estimated to be the fastest-growing region during the forecast period owing to rising diabetic population and awareness about animal insulins among patients and physicians, improving economic conditions in countries such as India & China, etc. Moreover, growing exports from developed countries such as Australia & New Zealand will fuel growth further due to their lower prices compared with that offered by U.S.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is expected to drive the demand for animal insulin in the coming years.
- Rising awareness about animal insulin: There is a growing awareness among people about the benefits of using animal insulin over human insulin. This is likely to boost the demand for this product in the near future.
- Technological advancements: The technological advancements in the field of diabetes care are helping to improve the efficacy and safety profile of animal insulin products. This is likely to propel their growth in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Animal Insulin Market Research Report
By Type
Porcine Insulin, Bovine Insulin
By Application
Humans, Animals
By Companies
Wockhardt UK, Eli Lilly, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Animal Insulin Market Report Segments:
The global Animal Insulin market is segmented on the basis of:
Types
Porcine Insulin, Bovine Insulin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Humans, Animals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Wockhardt UK
- Eli Lilly
- Merck
Highlights of The Animal Insulin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Porcine Insulin
- Bovine Insulin
- By Application:
- Humans
- Animals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Animal Insulin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Animal insulin is a type of insulin that comes from animals. It is different than human insulin, which comes from plants. Animal insulin can be used to treat diabetes in people.
Some of the major companies in the animal insulin market are Wockhardt UK, Eli Lilly, Merck.
The animal insulin market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Animal Insulin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Animal Insulin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Animal Insulin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Animal Insulin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Animal Insulin Market Size & Forecast, 2018-2028
4.5.1 Animal Insulin Market Size and Y-o-Y Growth
4.5.2 Animal Insulin Market Absolute $ Opportunity
Chapter 5 Global Animal Insulin Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Animal Insulin Market Size Forecast by Type
5.2.1 Porcine Insulin
5.2.2 Bovine Insulin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Animal Insulin Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Animal Insulin Market Size Forecast by Applications
6.2.1 Humans
6.2.2 Animals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Animal Insulin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Animal Insulin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Animal Insulin Analysis and Forecast
9.1 Introduction
9.2 North America Animal Insulin Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Animal Insulin Market Size Forecast by Type
9.6.1 Porcine Insulin
9.6.2 Bovine Insulin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Animal Insulin Market Size Forecast by Applications
9.10.1 Humans
9.10.2 Animals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Animal Insulin Analysis and Forecast
10.1 Introduction
10.2 Europe Animal Insulin Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Animal Insulin Market Size Forecast by Type
10.6.1 Porcine Insulin
10.6.2 Bovine Insulin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Animal Insulin Market Size Forecast by Applications
10.10.1 Humans
10.10.2 Animals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Animal Insulin Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Animal Insulin Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Animal Insulin Market Size Forecast by Type
11.6.1 Porcine Insulin
11.6.2 Bovine Insulin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Animal Insulin Market Size Forecast by Applications
11.10.1 Humans
11.10.2 Animals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Animal Insulin Analysis and Forecast
12.1 Introduction
12.2 Latin America Animal Insulin Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Animal Insulin Market Size Forecast by Type
12.6.1 Porcine Insulin
12.6.2 Bovine Insulin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Animal Insulin Market Size Forecast by Applications
12.10.1 Humans
12.10.2 Animals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Animal Insulin Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Animal Insulin Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Animal Insulin Market Size Forecast by Type
13.6.1 Porcine Insulin
13.6.2 Bovine Insulin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Animal Insulin Market Size Forecast by Applications
13.10.1 Humans
13.10.2 Animals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Animal Insulin Market: Competitive Dashboard
14.2 Global Animal Insulin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Wockhardt UK
14.3.2 Eli Lilly
14.3.3 Merck
